This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Use consistent tracking methods, categorize every expense, and summarize weekly to maintain tight control of monthly spending.
19,095 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Former official presses lawmakers to reclassify online event markets, arguing they are sports betting. The move inten...
Gold is leading gains in early 2026, while silver remains volatile. Analysts say the evolving ETF landscape is paving...
Insmed disclosed that Japan now hosts more MAC lung disease patients than the United States, a development that could...
STAG and EastGroup Properties stand out in the warehouse REIT space. This guide compares portfolio strategy, growth d...
U.S. stocks edged higher for the week even as oil prices surged, propelled by resilient corporate results and bets th...
Micron stock surged 700% over the past year, driven by AI memory demand. This guide breaks down what powered the rall...
A glamorous red-carpet moment offers more than style tips. This piece breaks down budget-smart wardrobe decisions, co...
The Clarity Act is moving toward markup with more than 100 amendments, spotlighting a fierce clash over stablecoin re...
Traders are increasingly turning to covered calls to generate income in a volatile market. One widely cited case clai...
Palantir shares moved higher as market chatter tied the AI and national security agenda to politics. Investors weigh ...
California’s CEQA exemption is speeding residential projects, yet fault lines surface as opponents deploy new delay t...